Local overexpression of C-type natriuretic peptide ameliorates vascular adaptation of porcine hemodialysis grafts

Kidney International

Volumn 65, Issue 5, 2004, Pages 1897-1905

  Rotmans, Joris I ^b   Verhagen, Hence J M ^b   Velema, Evelyn ^b   De Kleijn, Dominique P V ^b   Van Den Heuvel, Mieke ^b   Kastelein, John J P ^b   Pasterkamp, Gerard ^b   Stroes, Erik S G ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

Arteriovenous graft; C type natriuretic peptide; Gene therapy; Hemodialysis access; Intimal hyperplasia; Vascular remodeling

Indexed keywords

ADENOVIRUS VECTOR; CYCLIC GMP; NATRIURETIC PEPTIDE TYPE C;

ADAPTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOVENOUS SHUNT; BLOOD FLOW; BLOOD VESSEL OCCLUSION; CAROTID ARTERY; CONFERENCE PAPER; CONTROLLED STUDY; GENE; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; HEMODIALYSIS; HISTOLOGY; JUGULAR VEIN; LACZ GENE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VALIDATION PROCESS; VASCULAR PATENCY;

EID: 2342568373     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00598.x     Document Type: Conference Paper

References (46)

1. SCHWAB SJ, HARRINGTON JT, SINGH A, et al: Vascular access for hemodialysis. Kidney Int 55:2078-2090, 1999
2. KANTERMAN RY, VESELY TM, PILGRAM TK, et al: Dialysis access grafts: Anatomic location of venous stenosis and results of angioplasty. Radiology 195:135-139, 1995
3. ROY-CHAUDHURY P, KELLY BS, MILLER MA, et al: Venous neointimal hyperplasia in polytetrafluoroethylene dialysis grafts. Kidney Int 59:2325-2334, 2001
4. SWEDBERG SH, BROWN BG, SIGLEY R, et al: Intimal fibromuscular hyperplasia at the venous anastomosis of PTFE grafts in hemodialysis patients. Clinical, immunocytochemical, light and electron microscopic assessment. Circulation 80:1726-1736, 1989
5. SARTORE S, CHIAVEGATO A, FAGGIN E, et al: Contribution of adventitial fibroblasts to neointima formation and vascular remodeling: From innocent bystander to active participant. Circ Res 89:1111-1121, 2001
6. ZALEWSKI A, SHI Y, JOHNSON AG: Diverse origin of intimal cells: Smooth muscle cells, myofibroblasts, fibroblasts, and beyond? Circ Res 91:652-655, 2002
7. SUDOH T, MINAMINO N, KANGAWA K, et al: C-type natriuretic peptide (CNP): A new member of natriuretic peptide family identified in porcine brain. Biochem Biophys Res Commun 168:863-870, 1990
8. KOLLER KJ, LOWE DG, BENNETT GL, et al: Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science 252:120-123, 1991
9. KOMATSU Y, ITOH H, SUGA S, et al: Regulation of endothelial production of C-type natriuretic peptide in coculture with vascular smooth muscle cells. Role of the vascular natriuretic peptide system in vascular growth inhibition. Circ Res 78:606-614, 1996
10. IKEDA M, KOHNO M, YASUNARI K, et al: Natriuretic peptide family as a novel antimigration factor of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 17:731-736, 1997
11. MORISHIGE K, SHIMOKAWA H, YAMAWAKI T, et al: Local adenovirus-mediated transfer of C-type natriuretic peptide suppresses vascular remodeling in porcine coronary arteries in vivo. J Am Coll Cardiol 35:1040-1047, 2000
12. OHNO N, ITOH H, IKEDA T, et al: Accelerated reendothelialization with suppressed thrombogenic property and neointimal hyperplasia of rabbit jugular vein grafts by adenovirus-mediated gene transfer of C-type natriuretic peptide. Circulation 105:1623-1626, 2002
13. O'BRIEN T: Adenoviral vectors and gene transfer to the blood vessel wall. Arterioscler Thromb Vasc Biol 20:1414-1416, 2000
14. SMITH RC, WALSH K: Local gene delivery to the vessel wall. Acta Physiol Scand 173:93-102, 2001
15. KHURANA VG, WEILER DA, WITT TA, et al: A direct mechanical method for accurate and efficient adenoviral vector delivery to tissues. Gene Therapy 10:443-452, 2003
16. HAVENGA MJ, LEMCKERT AA, GRIMBERGEN JM, et al: Improved adenovirus vectors for infection of cardiovascular tissues. J Virol 75:3335-3342, 2001
17. ROTMANS JI, VELEMA E, VERHAGEN HJ, et al: Rapid, arteriovenous graft failure due to intimal hyperplasia: A porcine, bilateral, carotid arteriovenous graft model. J Surg Res 113:161-171, 2003
18. KOSSILA M, JAUHIAINEN S, LAUKKANEN MO, et al: Improvement in adenoviral gene transfer efficiency after preincubation at +37 degrees C in vitro and in vivo. Mol Ther 5:87-93, 2002
19. KALRA M, MILLER VM: Early remodeling of saphenous vein grafts: Proliferation, migration and apoptosis of adventitial and medial cells occur simultaneously with changes in graft diameter and blood flow. J Vasc Res 37:576-584, 2000
20. SHI Y, O'BRIEN JEJ, MANNION JD, et al: Remodeling of autologous saphenous vein grafts. The role of perivascular myofibroblasts. Circulation 95:2684-2693, 1997
21. LAITINEN M, PAKKANEN T, DONETTI E, et al: Gene transfer into the carotid artery using an adventitial collar: Comparison of the effectiveness of the plasmid-liposome complexes, retroviruses, pseudo-typed retroviruses, and adenoviruses. Hum Gene Ther 8:1645-1650, 1997
22. SCHNEIDER DB, SASSANI AB, VASSALLI G, et al: Adventitial delivery minimizes the proinflammatory effects of adenoviral vectors. J Vasc Surg 29:543-550, 1999
23. KOHNO M, YOKOKAWA K, YASUNARI K, et al: Effect of natriuretic peptide family on the oxidized LDL-induced migration of human coronary artery smooth muscle cells. Circ Res 81:585-590, 1997
24. CHRISMAN TD, GARBERS DL: Reciprocal antagonism coordinates C-type natriuretic peptide and mitogen-signaling pathways in fibroblasts. J Biol Chem 274:4293-4299, 1999
25. HORIO T, TOKUDOME T, MAKI T, et al: Gene expression, secretion, and autocrine action of C-type natriuretic peptide in cultured adult rat cardiac fibroblasts. Endocrinology 144:2279-2284, 2003
26. DOYLE DD, UPSHAW-EARLEY J, BELL EL, PALFREY HC: Natriuretic peptide receptor-B in adult rat ventricle is predominantly confined to the nonmyocyte population. Am J Physiol Heart Circ Physiol 282:H2117-H2123, 2002
27. QIAN JY, HARUNO A, ASADA Y, et al: Local expression of C-type natriuretic peptide suppresses inflammation, eliminates shear stress-induced thrombosis, and prevents neointima formation through enhanced nitric oxide production in rabbit injured carotid arteries. Circ Res 91:1063-1069, 2002
28. UENO H, HARUNO A, MORISAKI N, et al: Local expression of C-type natriuretic peptide markedly suppresses neointimal formation in rat injured arteries through an autocrine/paracrine loop. Circulation 96:2272-2279, 1997
29. GASPARI TA, BARBER MN, WOODS RL, DUSTING GJ: Type-C natriuretic peptide prevents development of experimental atherosclerosis in rabbits. Clin Exp Pharmacol Physiol 27:653-655, 2000
30. O'BRIEN JEJ, ORMONT ML, SHI Y, et al: Early injury to the media after saphenous vein grafting. Ann Thorac Surg 65:1273-1278, 1998
31. FANN JI, SOKOLOFF MH, SARRIS GE, et al: The reversibility of canine vein-graft arterialization. Circulation 82:IV9-18, 1990
32. DAVIES MG, HAGEN PO: Pathophysiology of vein graft failure: a review. Eur J Vasc Endovasc Surg 9:7-18, 1995
33. RODRIGUEZ E, LAMBERT EH, MAGNO MG, MANNION JD: Contractile smooth muscle cell apoptosis early after saphenous vein grafting. Ann Thorac Surg 70:1145-1153, 2000
34. WESTERBAND A, CROUSE D, RICHTER LC, et al: Vein adaptation to arterialization in an experimental model. J Vasc Surg 33:561-569, 2001
35. FEINFELD DA, BATISTA R, MIR R, et al: Changes in venous histology in chronic hemodialysis patients. Am J Kidney Dis 34:702-705, 1999
36. SIEREVOGEL MJ, PASTERKAMP G, VELEMA E, et al: Oral matrix metalloproteinase inhibition and arterial remodeling after balloon dilation: An intravascular ultrasound study in the pig. Circulation 103:302-307, 2001
37. SIEREVOGEL MJ, VELEMA E, VAN DER MEER FJ, et al: Matrix metalloproteinase inhibition reduces adventitial thickening and collagen accumulation following balloon dilation. Cardiovasc Res 55:864-869, 2002
38. CANAAN-KUHL S, OSTENDORF T, ZANDER K, et al: C-type natriuretic peptide inhibits mesangial cell proliferation and matrix accumulation in vivo. Kidney Int 53:1143-1151, 1998
39. DAVIDSON NC, BARR CS, STRUTHERS AD: C-type natriuretic peptide. An endogenous inhibitor of vascular angiotensin-converting enzyme activity. Circulation 93:1155-1159, 1996
40. STRAWN WB, FERRARIO CM: Mechanisms linking angiotensin II and atherogenesis. Curr Opin Lipidol 13:505-512, 2002
41. TAWARAGI Y, FUCHIMURA K, TANAKA S, et al: Gene and precursor structures of human C-type natriuretic peptide. Biochem Biophys Res Commun 175:645-651, 1991
42. OGAWA Y, ITOH H, YOSHITAKE Y, et al: Molecular cloning and chromosomal assignment of the mouse C-type natriuretic peptide (CNP) gene (Nppc): Comparison with the human CNP gene (NPPC). Genomics 24:383-387, 1994
43. NEWMAN KD, DUNN PF, OWENS JW, et al: Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia. J Clin Invest 96:2955-2965, 1995
44. CHANNON KM, FULTON GJ, GRAY JL, et al: Efficient adenoviral gene transfer to early venous bypass grafts: Comparison with native vessels. Cardiovasc Res 35:505-513, 1997
45. MAEDA Y, IKEDA U, OGASAWARA Y, et al: Gene transfer into vascular cells using adeno-associated virus (AAV) vectors. Cardiovasc Res 35:514-521, 1997
46. YASUDA S, KANNA M, SAKURAGI S, et al: Local delivery of single low-dose of C-type natriuretic peptide, an endogenous vascular modulator, inhibits neointimal hyperplasia in a balloon-injured rabbit iliac artery model. J Cardiovasc Pharmacol 39:784-788, 2002